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Management of Hypertension in Mental Health 
Patients in a Primary Care Setting 







 Numerous studies have revealed that mental health patients tend to receive poor quality of health 
care for their medical conditions.  This tendency has been attributed variously to numerous issues, 
including stigmatization.  In his experience working in the Metro District Health Services Clinics of the 
Department of Western Cape, the researcher has encountered numerous cases of sub-standard quality of 
medical care for mental health patients.  These encounters, as well as a need to audit the general quality of 
care of patients with chronic diseases of lifestyle, have been the motivation behind the creation of this 
research project. 
 The study is a retrospective cohort study using patient folders as a source of data.  It compares the 
standards, processes and outcomes of the management of hypertension in two populations at Crossroads 
Community Health Clinic in Cape Town.  The first cohort consists of hypertensive patients with 
psychiatric illnesses, and the second are hypertensive patients without psychiatric illnesses.  The study 
attempts to examine the quality of care of established hypertension in patients with psychiatric illnesses.  
Folders were examined for the recording of various activities and actions (during consultations) that are 
essential to the assessment, modification and prevention of complications. 
 The results reveal a significant difference between the care of psychiatric patients with 
hypertension and non-psychiatric hypertensive patients at Crossroads CHC, with regard to 
counselling about diet changes, the measurement of blood pressure at relevant visits, and the 
weighing of patients annually.  Furthermore, basic equipment essential to the optimal 
management of hypertension is not available in the consulting room where the psychiatric 
patients are seen.  Both groups are sub-optimally managed according to national standards, and a 
statistically significant but epidemiologically equivocal difference is found between the two 

















Crossroads Community Health Clinic (CHC) is a primary health clinic located in the 
peri-urban settlement of Crossroads in Cape Town South Africa.  The community is 
predominantly unemployed and poor, consisting of mostly Xhosa speaking people.  The clinic is 
one of numerous eight hour clinics located throughout the province and falls under the auspices 
of the Provincial Administration of the Western Cape Department of Health (PAWC DoH), 
through the Metropolitan District Health Services (MDHS).  Crossroads CHC is one of four 
community health clinics in a sub-district (Mitchell’s Plain/Klipfontein) with a population of 
approximately 115,000 people.1  It provides primary health care through coordinated services 
falling under eight national health priority areas/programmes.  These areas include HIV/AIDS 
and STI screening, prevention and treatment, Chronic Diseases of Lifestyle treatment and 
prevention, Women’s Health (Cervical Cancer screening), Tuberculosis treatment and screening, 
Child care and immunization, Mental Health, and home based care.   
The clinic employs six medical doctors and three clinical nurse practitioners involved 
with the consultation of patients, as well as an extensive professional nursing staff.  Three of the 
medical doctors and two of the clinical nurse practitioners work in the general clinic side, while 
the other doctors and clinical nurse practitioners work in the anti-retroviral clinic.  The clinic 
employs a club system, whereby patients with the national priority chronic diseases 
(hypertension, asthma, epilepsy, diabetes) are seen on selected days.  These patients are gathered 
in the club room upon arrival where they are prepared (blood pressure, glucose, peak flows, 
seizure frequency, etc. are measured and recorded) and health education is provided before they 
proceed to the consultation rooms.   
Mental health patients are seen from Monday to Thursday by a professional mental health 
nurse practitioner.  A psychiatry registrar visits the clinic weekly to see scheduled problematic 
cases and periodic review cases.  Psychiatric patients with hypertension are often sent to the 
hypertension club after their psychiatric consultation with the psychiatric nurse and reviewed by 
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clinic seems to suggest that these patients are not being managed as well as they could.  Many 
are not always sent to the club room, but go directly to the doctor on call, and those who are sent 
to the club room first do not seem to get the same attention as their non-psychiatric counterparts.  
The most common explanation has been the significant general volumes of patients seen each 
day.  Furthermore, these patients often see the medical doctor after having seen the mental health 
sister and having gone to the club.  They are arguably often tired and in a rush to have their 
hypertensive medications re-boarded and to go to the pharmacy.  
  As part of a quality improvement initiative for the management of hypertension at the 
clinic, the reason for this study is to better ascertain and articulate the quality of care of 
hypertensive psychiatric patients, and to compare it to the quality of care given to their non-
psychiatric counterparts.  An added consequence of the study will be to examine the care of non-
psychiatric hypertensive patients at the clinic as part of the first step in a quality improvement 




Is there a difference in the quality of management of hypertension in patients with psychiatric 




Is there a difference in the resulting levels of blood pressure control between the two groups of 
patients? 
 
















	  Hypertension	  as	  a	  Public	  Health	  Priority	  
 
Hypertension continues to be a significant worldwide cause of morbidity and mortality, 
with more than 25% of the world’s adult population suffering from it in 2000.2  This proportion 
is projected to increase to a total population of 1.56 billion by 2025. 2 The disease’s attendant 
higher risks of other cardiovascular diseases and complications (stroke, heart failure, etc), make 
it one of the more significant contributors to the burden of disease and mortality in many parts of 
the world.3  Indeed, as of 2002, hypertension was responsible for 7.1 million deaths (13% of 
total).4     In Sub-Saharan Africa (2000), the rates of hypertension among people between the 
ages of 40-49 was 38.5% for men and 39.5% for women, with rates increasing with age to as 
high as 61.0% for women between the ages of 60-69 and 57.4% for their male counterparts.2  
While these rates may be less than rates in economically developed regions, the anticipated 
increase in global rates of hypertension by 2025 is expected to be due predominantly to a more 
rapid rise in rates of hypertension in economically developing regions like Sub-Saharan Africa.2  
This rise has been attributed to what has been called elsewhere the epidemiologic transition, 
where the gradual economic development of a region leads to a shift in the primacy of certain 
diseases like infectious disorders to diseases like hypertension and diabetes.5   
South Africa’s peculiar history of apartheid leaves it with what has been called a dualistic 
economy characterised by one part of the population living and participating in a developed 
economy, while the majority of people remain in a poorer developing economy.6  As a result, the 
population suffers from diseases on both proverbial sides of the epidemiologic transition.5 
Communicable diseases like HIV/AIDS and Tuberculosis remain the commonest causes of 
premature death in the country.5 However, among the numerous complications of hypertension, 
stroke is the most common cause of premature death by a non-communicable disease, and 
hypertensive heart disease is not far behind.7  In fact, the estimated total cost of cardiovascular 
disease in South Africa in 1991 was between R4.135 billion and R5.035 billion.8  The direct 
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these total costs.8  In addition, results from the South African Demographic and Health Survey of 
1998 revealed that 21% of the South African population is hypertensive.9 The survey was 
performed on 13,802 randomly selected individuals whose blood pressures were checked in their 
homes, and a measurement of 140/90mmHg used as the defining cut-of point for high blood 
pressure.9a  These aforementioned global and South African actualities make hypertension a 
public health priority.  Indeed, the WHO (with the South African government following suit) has 
made it one of the chronic diseases of lifestyle that require special public health policy 
attention.10,11  
The Alma Ata declaration of 1978 outlines an approach to health care whose “central 
function and main focus” is primary health care.12  Accordingly, this philosophy permeates the 
South African government’s approach to health care, where the district health system is the 
coherent structural instrument through which primary health care is delivered.13  The country’s 
health care policies articulate a belief that within and through the district health system, primary 
health care can begin to effectively address the prevalent health concerns of the public, including 
the effective and efficient treatment of hypertension.13  
 
Obstacles	  to	  the	  Management	  of	  Hypertension	  
 
Perhaps one of the more difficult challenges to any government’s attempts to implement 
policies, is the monitoring and evaluation of the impact of these policies.  It is a challenge that 
presents itself at all levels of the instruments of government.  Within the context of health care 
and the practice of medicine, this challenge conflates with the persistent attempts to shorten the 
distance between clinical evidence and clinical practice.  The ultimate goal is the improvement 
of clinical and health outcomes.  With hypertension, as with other chronic diseases of lifestyle, 
numerous obstacles obtain in the implementation of evidence-based practices.  This fact is 
clearly evidenced by the generally poor quality of management of patients with hypertension. 
                                                
a  The Joint National Committee on Detection, Evaluation, and Treatment of High Blood pressure guidelines (JNC 
VI) were followed by the investigators with regard to the measurement of blood pressure by trained standardized 
fieldworkers (i.e. three measurements taken three minutes apart after five minutes of rest, in a seated position using 
the left arm at heart level and palm facing up).7  However, due to the obvious magnitude and logistical difficulties of 
such a study, blood pressures were not measured again a month later in keeping with recommendations, suggesting a 
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Ornstein and Jenkins’ audit of process and outcome measures in forty-eight primary care 
practices in the United States is revealing.14  In their audit of the quality of care of chronic 
illnesses (Asthma, Hypertension, Diabetes, Coronary Heart Disease, Stroke, and Atrial 
Fibrillation) in 1998, the authors found that of the 19,412 patients with more than three recorded 
measurements of blood pressure above 140/90mmHg (criterion for diagnosis), only 45% were 
diagnosed with hypertension.14 Furthermore, only 38.1% of the 14,119 patients with the 
diagnosis of hypertension had normal blood pressure readings (less than 140/90) at the end of the 
period being assessed.14  In South Africa, an assessment of the quality of care of hypertensive 
patients was recently performed by Rayner et al. at two CHCs in Cape Town.15  The researchers 
used a patient completed questionnaire to assess various aspects of the process of care at the two 
clincs.15  Their findings revealed that numerous aspects of the process of care of hypertensive 
patients were lacking, including, proper blood pressure measurement, education about lifestyle 
changes, risk stratification, and prescription of appropriate medication.15  Furthermore, they 
found that only 39.8% of the patients had target level blood pressures (<140/90), compared to 
42.1% in an earlier study by Steyn et al.15,16  It is important to note that Rayner et al.’s findings 
are almost similar to Ornstein and Jenkins’ 1998 findings and to Steyn et al.’s earlier 
findings.14,15,16 These results also compare roughly with the third United States National Health 
and Nutrition Examination Survey (NHANES III) conducted in two phases between 1988 and 
1994, which found that only 46.9% of diagnosed and treated American patients with 
hypertension (1988-1991) had controlled blood pressures below 140/90mmHg.17 However, the 
fourth NHANES (1999-2000) finds an improvement in the United States population, where 
53.1% of patients diagnosed and under treatment for hypertension were well-controlled 
(<140/90).18  This improvement is consistent with a trend of improvement since the first of these 
surveys was performed in 1960-62, although the first two surveys used an older definition of 
blood pressure control (160/95) and measured blood pressures using a different standard of 
measurement.18 The levels of control in the two South African community health clinics studied 
by Rayner et al. therefore compare poorly to the already low latest levels of control found 
amongst American patients.15,18 The question that naturally arises, is what are the obstacles to 
better care and how can they be addressed?   
Many of these obstacles are created by health care workers themselves and revolve 
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hypertension.  For instance, in their retrospective cohort study of the care of hypertensive 
patients by clinicians in a health management organisation (HMO) in the United States, Andrade 
et al. found that primary care physicians were more likely (odds ratio=11.51 with a 95% 
confidence interval of 6.08-21.50) to intensify antihypertensive therapy in patients whose blood 
pressure was substantially elevated (>180mmHg systolic), as opposed to patients whose 
pressures were moderately elevated of 140-149 mmHg (odds ratio of 1.51 with a 95% 
confidence interval of 0.88 to 2.59).19 Even at higher systolic pressures of 160-169, the 
likelihood of intensifying therapy was not as high (2.88 (1.65, 5.02)) as when the systolic blood 
pressure was greater than 180mmHg.19   
It is important to note that Andrade et al.’s study has a few shortcomings, notably when 
their adjusted odds ratios are more closely examined for likelihood of intensification relative to 
blood pressure levels.19  In their analysis, they rightly adjust the abovementioned odds ratios to 
other confounding variables which could influence physicians’ decisions to intensify or continue 
treatment in addition to the blood pressure reading.19  These additional, potentially influential 
variables include the patient’s age, coexisting cardiovascular disease and diabetes, days or weeks 
since previous, smoking status, medication intensification at last visit, and number of medication 
intensifications in the past year.19 When these variables are included, the likelihood of 
medication intensification still increases with higher systolic and diastolic pressures, particularly 
with systolic blood pressures above 180 but, the confidence intervals overlap considerably.19  For 
example, the adjusted odds ratio (OR) for medication intensification with systolic blood 
pressures greater than 180mmHg was 7.33 with a wide 95% confidence interval (2.92, 18.40), 
which overlaps with that of the lower odds ratio of 1.60 for the intensification of treatment at 
systolic pressures between 150-159mmHg (0.82, 3.12).19 This latter odds ratio in turn has 
overlapping confidence intervals with the adjusted odds ratio for the intensification of 
medication at blood pressures between 140-149 (1.02 (0.53, 1.98)).19 This means that in the 
wider population it may be just as likely for  physicians to intensify medication for moderately 
high blood pressures as for very high recordings, in spite of the large differences found in the 
study.  Nonetheless, Andrade et al.’s findings and acclamations correspond to Hyman and 
Pavlik’s findings that primary care physicians have a higher threshold for treating or intensifying 
treatment of hypertension than the lower, evidence-based recommendations of the Joint National 
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379 primary care physicians who responded to their survey, 52% indicated that they would not 
initiate anti-hypertensive therapy in middle-aged patients with systolic blood pressures (SBP) 
between 140 and 160mmHg, while only 24% would initiate treatment in patients aged 70 years 
or older, with SBPs less than 160mmHg.20  
In yet another study of barriers to physicians’ adherence to recommended treatment 
protocols, Oliveria et al. found that the commonest reason for physicians’ high SBP threshold for 
changing anti-hypertensive drug treatment was that the doctor was content with the blood 
pressure (46% of responses).21  Of course, other barriers to the proper management of 
hypertension exist.  These involve patient-related factors--which many health care workers find 
challenging to address--like diet and lifestyle changes, adherence difficulties and poor access to 
care.  Adherence itself has many contributing factors, including inadequate patient education 
about hypertension and its treatment.22  Further barriers include adverse drug effects as well as 
the difficulties of attending to and monitoring patients’ existing drug regimens and their potential 
interactions.19,20  While some barriers to better management of hypertension like access to care 
involve complicated infrastructural and intersectoral interventions, others are more surmountable 
in the short term.  These other barriers are often the targets of quality improvement endeavours 
within existing care delivery centres like clinics and hospitals, and form part of the larger 




The quality improvement cycle, whose basic instrument is the clinical audit, is a valuable 
and dynamic method of assessing the quality of care in any clinical service setting, and providing 
a process through which service can be improved.23  It is a crucial part of what has come to be 
described wholly as clinical governance, which is an extensive mechanism of implementing and 
sustaining a high quality of service in national health systems.24  Furthermore, quality 
improvement through clinical audits can be particularly helpful with chronic disease 
management, where numerous evidence-based guidelines and protocols can be used as standards 
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Mash and Levitt demonstrate the possibilities in the use of the quality improvement cycle 
with their work in a community health clinic in Khayelitsha, Cape Town.25  In their examination 
of the structure, process and outcomes of the care of diabetes sufferers between 1996 and 1997, 
all standards for structure except one (availability of cotton wool and disposable pins) were 
achieved by 1997, even though only one standard for the process of care was attained (90% of 
patients weighed at last clinic visit), and no standards of outcome were significantly achieved.25  
Nonetheless, the results of the audit allowed for further discussions in the clinic about how to 
adjust clinical practices in order to attain better results for 1998.25 
Mash and Whittaker performed a similar audit of the management of Asthma in a Cape 
Town clinic.26  These exercises are equally possible with the management of hypertension.  
Indeed, in their systematic review of quality improvement for hypertension, Walsh et al. 
concluded that quality improvement strategies (of which clinical audits are a type) are associated 
with better control of the disease.27  However, audit and feedback studies were a very small 
percentage of those reviewed (5 of 44 studies).27  
A recent pre- and post-intervention study of community health centres involved in quality 
improvement exercises based on clinical audits in the United States showed an overall significant 
improvement in the quality of care scores for the management of patients with Asthma, Diabetes 
and Hypertension compared with centres where no audit-based quality improvement cycles were 
implemented.28  These improvements were found notably in process-related measures concerned 
with the monitoring and treatment of the diseases, indicating that the quality improvement cycle 
using clinical audits can play a meaningful role in changing clinical practice and improving 
adherence to evidence-based practice guidelines.28 However, it is important to note that the study 
did not find any post-intervention improvement in clinical outcomes.28 Moreover, the process of 
care measures for hypertension specifically, were not significantly improved.28  Nonetheless, the 
study was examining intermediate outcomes (one year after the interventions), whereas some of 
the process measures (e.g. smoking cessation advice and the use of aspirin for men at risk of 
coronary artery disease), have been shown elsewhere to be more relevant to longer term clinical 
outcomes, which were beyond the scope of this study.28,29 Additionally, other factors also 
contribute to clinical outcomes, including patient adherence (and its attendant environmental 










Page | 13 
 
In separate study by Mashru and Lant, the use of peer review medical audit was tested for 
its effect on changing clinical practice.30  The authors audited the records of 740 hypertensive 
patients from 25 randomly selected general practitioners serving 12% of a district in the north 
west London.30 An educational intervention involving the review and dissemination of the latest 
best practice guidelines was implemented and the medical audit repeated.29  The intervention 
resulted in changes and significant improvements in the processes of care, including recording of 
body mass index (BMI), urea and electrolyte results, as well as total cholesterol levels, but no 
improvement was seen in blood pressure control.30   Therefore, quality improvement may still 
have a valuable place in the monitoring, evaluation and improvement of clinical practice, 
particularly if it is focused predominantly on the structures and processes of care, while 
attempting to address how to examine longer term outcomes.   
        
 
 
Psychiatric	  Patients	  and	  Medical	  Problems	  
 
Patients with psychiatric conditions in general tend to receive poorer medical care than 
their non-psychiatric counterparts.  In fact, even standard preventive medical care has been found 
to be of lower quality.31  The reasons for poorer medical care have been variously ascribed to 
numerous factors including, poor access to health, discrimination and stigmatization and non-
adherence to medication.32  These actualities particularly pose a challenge to the management of 
chronic medical conditions among these patients.  Moreover, the importance of this challenge 
lies in the fact that patients with mental illnesses like schizophrenia are already at higher risk of 
chronic diseases (especially Type 2 Diabetes) than the general population.33  Elsewhere, Brown 
et al. measured standardised mortality ratios (SMRs) in their 13-year follow-up of 370 
schizophrenia sufferers and concluded that deaths from circulatory, respiratory and endocrine 
diseases were significantly higher than in the general population.34  The researchers also cite 
poor medical treatment as one of the contributing factors to the excess mortality.34 This assertion 
is further substantiated by Kreyenbuhl at al.’s study of the management of diabetes in 201 
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management in 99 diabetic patients without a serious mental illness.35  The study revealed that 
diabetes was less aggressively managed in the patients with serious mental illnesses (SMI) and 
this was manifested by a lower likelihood to receive cholesterol lowering statin medication (29% 
as likely for patients with schizophrenia and 14% as likely for those with mood disorders).35 
They were also less likely to receive angiotensin converting enzyme inhibitors (ACEI) or 
angiotensin receptor blocking agents (ARB) than their counterparts without mental illnesses.35 
Obesity is another chronic disease of lifestyle among mental health patients, especially 
sufferers of schizophrenia.36  Its prevalence is further exacerbated by the lack of exercise among 
patients with mental illnesses.37 Additionally, antipsychotic medications are also associated with 
weight gain; a recent meta-analysis confirmed that the atypical antipsychotic agents, clozapine 
and olanzapine had caused the largest amount of weight gain after ten weeks of treatment.38 Of 
course obesity is itself associated with cardiovascular complications like coronary heart disease, 
hypertension and stroke, thus adding to the complexity of medical disorders among mental health 
patients.  
          
    Hypertension specifically is a prevalent chronic disease of lifestyle among this group 
of patients.39  Most notable is its higher prevalence among patients with bipolar disorder and 
those with anxiety.40 Non-adherence to medication has been proposed as an important 
influencing factor to the control of hypertension both among psychiatric and non-psychiatric 
patients.22,41 In an elegant study of a large population of American veterans with concurrent 
schizophrenia, hypertension and diabetes, Piette et al. attempted to examine intra-patient 
variations in adherence to anti-psychotic versus antihypertensive versus hypoglycaemic 
medication.41  The authors used medication possession ratios (MPR)—a well-validated proxy 
measurement of adherence based on patients’ patterns of refilling their prescriptions at Veterans 
Administrations (VA) Hospitals’ outpatient pharmacies—to compare how well patients adhered 
to the different classes of drugs.41  Their extensive multivariate logistic regression analysis 
(including such possible confounders as distance from hospital, days of supply or refill intervals, 
number of mental health and number of medical visits), revealed a higher likelihood of non-
adherence to antihypertensive and hypoglycaemic medication than to antipsychotics (Adjusted 
odds ratio 1.5 p<0.001).41  Possible explanations include less vigilant practitioner attention to 
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schizophrenia.41  This explanation would fit well with the aforementioned theme of poor medical 
care for psychiatric patients.  Of course, medication adherence is a perennially difficult entity to 
measure and the MPR is only a proxy and not a direct measurement of it.  Furthermore, the 
authors make no attempt to factor the filling of medical prescriptions from pharmacies outside 
the Veterans’ Administration by the patients as this would be logistically impossible for the 
population studied (N=1,686).41  
Siegel et al. also found lower rates of adherence to anti-hypertensive medications among 
hypertensive patients with major depression who received treatment from the Department of 
Veterans Affairs in the United States.42  The groups also used medication possession ratios to 
approximate adherence among 40,492 patients who were on at least one antihypertensive 
medication over an eighteen month period.42 Multiple logistic regression was again used to 
identify predictors of adherence in this population, and numerous possible confounders like age, 
gender, and facility were included, although unlike Piette et al.’s study, the researchers did not 
include distance from hospital.41,42 Interestingly, while depression was found (followed by race, 
with African-Americans being least likely to be adherent) to be the associated with the worst 
adherence to anti-hypertensive medications (odds ratio=0.861 CI:(0.75,0.9) p<0.001), dementia 
and psychosis were not, presumably because many patients with psychosis or Alzheimer’s are 
more likely to have a carer assisting their medication.41  These findings do not necessarily 
contradict Piette et al.’s findings, as they were looking specifically at patients with 
Schizophrenia, as opposed to other causes of psychosis (in fact Siegel et al. are unclear about 
how they categorized depression with psychotic features).41,42  In addition, while suffering from 
Schizophrenia--as viewed from the concluding lens of Siegel et al.’s study—may not necessarily 
be a predictor of poorer adherence to antihypertensive medication, this does not negate the 
finding that this level of adherence is still lower than the level of adherence to anti-psychotic 
medication as was found in Piette et al.’s study.41,42  In fact, to reiterate the different approaches, 
Siegel’s group does not differentiate the different subsets or causes of psychosis, and it may well 
be that schizophrenia by itself, as a subset of this group, is associated with a higher likelihood of 
poor adherence to anti-hypertensive medication.41,42           
However, in their comparison of adherence and blood pressure control in middle aged 
and older patients with psychotic disorders versus patients without psychiatric illnesses, Dolder 
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conditions.43  Naturally, this finding reiterates the fact that control of hypertension involves 
numerous factors including lifestyle modification and appropriate drug regimens.44  These are 
aspects of the care of hypertensive patients that may not be as adequately attended to in patients 
with psychiatric illnesses.43 Crossroads CHC provides an ideal opportunity to examine this 
possibility of differing quality of care and to examine it using an audit template provides an 
excellent, structured platform from which quality improvement interventions can be made.  
Moreover, it conflates very well with the South African government’s newly restructured health 
care plan (Healthcare 2010) which aims to approach mental health care in a more integrated and 















The objectives of the study were to perform an audit of the structure, process and 
outcome of hypertension management in two groups of patients at Crossroads CHC, namely 
psychiatric patients with hypertension and non-psychiatric patients with hypertension.  Further 
objectives were to determine if there is a significant difference in the quality of care between the 








Based on the South African National Hypertension guidelines of 2006, a questionnaire 
(audit instrument) was designed to examine the various measures of the structure, process and 
outcomes in the management of hypertensive patients.44 Each of the consultation rooms where 
hypertensive patients are seen by a doctor (typically after being prepared and receiving education 
in the club), was assessed using the audit instrument by the researcher.  The club room and the 
injection/procedure room were also examined using the audit instrument.        
Folders of patients from the hypertension club aggregate at the pharmacy after patients 
have completed their transit through the clinic.   Of course, these folders also include patients 
who have come only to collect their month’s supply of medication.  The clinic only gives two 
month supplies of medication in December for patients going to the Eastern Cape for the 
holidays.  Therefore, almost all the active hypertensive patients’ folders pass through the 
pharmacy at least once a month.  All folders of patients with hypertension at Crossroads CHC 
are uniquely identified by a red sticker for better filing.   
Throughout a four week period in May 2008, folders belonging to non-psychiatric 
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data collection, the clinic did not have a current and updated register of the total number of non-
psychiatric patients with hypertension.  However, it was assumed that most if not all the current 
hypertensive patients at the clinic should have their folders pass through the pharmacy at least 
once in any given month, either after a visit to the club and a consultation, or after coming to the 
clinic only to collect medication.  The clinic’s pharmacy very rarely gives out more than a 
month’s supply of pills, and only does so for large groups of patients in the months of November 
and December.    
   At the end of each hypertensive club day (Tuesday to Friday), every third folder was 
selected from the pile of hypertension folders at the pharmacy.  These folders were examined 
using the audit instrument and returned the following day to the clinic’s reception.  Although 
patients with hypertension rarely attend the clinic more than twice in one month, folder numbers 
were also recorded during the data collection process to avoid duplication of entries.        
Given the smaller total population of psychiatric patients diagnosed with hypertension at 
Crossroads CHC, all the folders of psychiatric patients with hypertension were collected from the 
reception records.  All folders belonging to psychiatric patients are stored in a separate filing 
cabinet in the clinic’s reception and are marked with a silver sticker.  Folders of psychiatric 
patients with hypertension were identified using the additional red stickers found on their covers.  
Furthermore an incomplete list of hypertensive mental health patients was used, which had been 
irregularly compiled over the previous nine months by the mental health nurse.  The use of this 
list enabled the researcher to find any added folders of current or active patients whose folders 
may not have had a red sticker in spite of having been diagnosed as hypertensive.  This was 
particularly crucial for the psychiatric patient population given that the total population of 
hypertensive patients in this group was smaller than was expected.  However, not all of these 
unlabelled folders may have been on the mental health nurse’s aforementioned list, as this list 
was admittedly not exhaustively or consistently filled.  Therefore, the folders collected cannot 
confidently be said to represent the entire population of known psychiatric patients with 
hypertension, but may be the best possible estimation.       
The audit instrument was used to measure the process of care of hypertensive patients 
based on the folder notes.  It was assumed that if an activity or action was not recorded in the 
notes (e.g. diet education per visit or creatinine measured in the past year), it was not performed.  
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to a non-smoker) were marked as such (N/A).  Folders were also examined for already existing 
cardiovascular disease (defined as stroke, ischaemic heart disease, clinical cardiac disease or left 
ventricular hypertrophy), target organ damage, hypercholesterolaemia, and diabetes.  Where the 
existence of these conditions was unknown or unrecorded, it was noted as such.  The activity 
labelled ‘Medication Education/year’ was used to identify activities in the consultation room 
involving pill counts and education about how to take the medication.  Often, patients are 
requested to bring their pill packets in order to review whether they are taking their various pills 
as prescribed on the packets, and to count pills as an approximation of adherence.    
The last or most recent blood pressure measured and recorded during the period being 
assessed (May 2007-May 2008) was recorded for each patient using the audit instrument.    
 
Population and Selection 
 
For both cohorts, only folders belonging to patients who had been seen by a doctor or the 
mental health professional nurse at least twice in the preceding twelve months (May 2007-May 
2008) were used.  This is the minimum allowable number of consultation visits in a year, as 
prescriptions may not exceed six months.  Furthermore, folders were excluded from the study if 
patients were diagnosed with hypertension after only one reading and were immediately placed 
on treatment, after which subsequent readings were normal.  These patients may not be truly 
hypertensive, as the diagnosis should be made after a minimum of three blood pressure 
measurements taken on three separate occasions (preferably at the same time of day) within a 
two months period in keeping with the South African National guidelines.44  However, those 
who were diagnosed with hypertension and placed on treatment on their first visit, but whose 
blood pressure remained elevated on subsequent visits, were assumed to be hypertensive and 
included in the study.  Hypertension was defined (in keeping with current national and 
international guidelines) as BP ≥140/90 mmHg.44 
As previously mentioned every third non-psychiatric hypertensive folder was collected 
every Tuesday to Friday from the Pharmacy and perused using the audit instrument, then 
returned to the reception the following day.  In accordance with the research protocol, this 
process was also attempted for psychiatric patients with hypertension, whereby their folders were 
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much smaller than expected, and a decision was made by the researcher to include all folders 
belonging to psychiatric hypertensive patients as heretofore described. The most practical, initial 
sample size calculated for both populations was 212 in order to pick up a difference of at least 
11% when comparing proportions from each group.46  Smaller differences in proportion would 
have required a higher population of patients (towards 600) which would not have been feasible 
given the resources available for this study.46     
 
Analysis Methodology 
 In both cohorts, the number of folders where each activity was performed (e.g. blood 
pressure measured at each visit) was converted to a proportion and the two proportions 
compared.  The mean final (end of period/year) systolic and diastolic pressures were calculated 
for each cohort.  The two-tailed Fisher’s exact test was used to compare the proportions of all 
categorical variables in each group, with the modified Wald method used to calculate confidence 
intervals for these proportions.47  Means of continuous variables (age and blood pressure) were 
compared using the unpaired student’s t-test for normally distributed data (with Welch’s 
correction for data with statistically different standard deviations), and the Mann-Whitney test 
(which compares medians) for non-parametric data.47  
A review of the literature reveals little consensus and great variation in how different 
audits of hypertensive management define and assess outcome and control.  Some studies use the 
most recent blood pressure measured during the period being studied, whereas others use an 
average of all the blood pressure measurements or the last two or three blood pressure 
measurements in that period.48,49 For the purposes of the audit, blood pressure control was 
defined as the last or most recent blood pressure recorded during the period being less than 
140/90mmHg in keeping with national guideline definitions of good control.44 This decision was 
based mainly on the fact that the number of visits to the clinic per year varies with each patient 
from as few as two (six months apart) to as many as twelve (monthly).  The differing periods of 
time between blood pressure measurements has been cited as one of the shortcomings of using 
the last few measurements of the period being studied.44,50 Furthermore, using the mean of the 
last two or three blood pressures for patients with as few as three visits throughout the entire year 
would not give an assessment of the level of control at the end of the period, but simply yield 
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The proportions of patients with the most recent or last blood pressure measurements 
below the aforementioned limit (140/90) for the period in question were compared across the two 
groups using the two tailed Fisher’s exact test.47 The proportions of patients in each group with 
an isolated, controlled last systolic blood pressure less than 140mmHg or an isolated, last 
diastolic pressure less than 90mmHg were also compared between the two groups.  Lastly, the 
mean last systolic and diastolic pressures were calculated and compared between the groups 
using the Student’s t test, and the medians compared using the Mann-Whitney test, whenever the 
data were found to be non-parametric.47 All statistical tests were unpaired and two-tailed.47 
  
   
Ethics 
 
 The study was approved by the Facility Manager of Crossroads CHC as well as the 
University of Cape Town Research Ethics Committee.   
    
Results and Analysis 
 
Demographics 
 Folders belonging to one hundred and eighty-six non-psychiatric patients with 
hypertension and forty-eight psychiatric patients with hypertension were collected during the 
previously mentioned four week period.  Amongst the non-psychiatric folders, twenty were 
excluded because the diagnosis of hypertension was questionable based on the aforementioned 
selection criteria.  Two of the folders had already been collected and assessed the week before. 
The patients were attending the clinic again that month for new acute problems (unscheduled 
visits).  One folder was missing sheets with notes and information pertaining to the period in 
question (May 2007-May 2008).    
 Of the folders belonging to psychiatric patients, seven were excluded because of a 
questionable diagnosis of hypertension and nine were excluded because they had not been seen 
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 The final total number of patient folders qualifying for the study was one hundred and 
sixty three non-psychiatric and thirty-two non-psychiatric patient folders.  For both cohorts, the 
majority of patients were females, and the mean age was similar (52.5 vs. 55.4), as seen in Table 
1.b  Other data were not recorded in all of the folders and therefore could not be properly 
assessed (Table 1.)  Furthermore, demographic data like education level were not recorded at all.  
44% of the psychiatric patients were schizophrenic, 38% suffered from major depressive 
disorder (one of whom also had post-traumatic stress disorder), 9 % from schizoaffective 
disorder, and a further 6% suffered from bipolar affective disorder.  One patient (3%) had 
behaviour disorder not otherwise specified, as well as being mentally disabled (Global 
assessment of function=60) and deaf from congenital rubella.            
 
Table 1. Patient Demographics  
 
Characteristics Psych Patients (n) Non-Psych Patients 
(n) 
P values 
Total Population (N) 32 163 N/A 
Males % 16 (5) 25 (41) 0.37 (Fisher’s Exact) 







55.4±9.9 0.1 (unpaired t-test) 
CI  (-0.59 to 6.5) 
Recorded Alcohol use 
% 
3 (1) 8 (13) 0.47 (Fisher’s 
Exact)* 
Recorded Smoker % 22 (7) 9 (15) 0.02(Fisher’s Exact) † 
Recorded Exerciser % 9.4 (3)  8.6 (14) 0.07(Fisher’s Exact)‡ 
*Alcohol use was unknown/not recorded for 9 psychiatric patients and 43 non-psychiatric patients. 
Comparison made for recorded population.  
†Smoking status was unknown/not recorded for 9 psych patients and 23 non-psych patients. Comparison 
made for recorded population. 




                                                
b The ages of psychiatry patients were found to be parametric based on one out of three tests for normality (KS, 
D'Agostino & Pearson omnibus, and the Shapiro-Wilk normality tests were used) while all two of the three tests 
found the non-psychiatric patients’ ages to fit a normal distribution.45 The standard deviations were not found to be 
statistically significant.  The t-test therefore was used because of its higher power, but using the Mann-Whitney test 
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 There was no significant difference between the two cohorts in the prevalence of pre-
existing diabetes, target organ damage, cardiovascular disease, or the regular use of non-steroidal 
anti-inflammatory medication (Table 2).  However, a considerable number of patients had never 
been screened for these conditions.  29% of the non-psychiatric patients had never been screened 
for diabetes, and the majority of patients in both cohorts had never been screened for cholesterol, 
cardiovascular disease, or target organ damage.  More specifically, the presence of pre-existing 
cardiovascular disease was unknown (or unrecorded if known) in 84% of the psychiatric patients 
and in 46% of the non-psychiatric patients.   
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c 95% Confidence interval for difference between proportions cannot be calculated if one of the absolute values (n) 
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In both groups, the majority of patients (41% of the psychiatric patients and 35% of the 
non-psychiatric patients) were on two anti-hypertensive agents (Table 3).  There was no 
statistically significant difference between the proportions of patients on one, two, three, or more 
than three agents between the two groups (Table 3).  For the psychiatry cohort, patients on two 
or less agents were a majority (73%), while patients on two or three agents (61%) constituted the 
majority of patients in the non-psychiatric group (Table 3).  This difference was also not 
statistically significant (p=0.54, CI for difference between percentages: (-11, 25)).   
According to the 2006 National Guidelines, the recommended first three pharmacological 
lines of treatment in the management of hypertension should be a thiazide (Hydrochlorothiazide 
at Crossroads CHC) or thiazide-like diuretic, an angiotensin-converting enzyme inhibitor (ACE-
I: Enalapril at Crossroads CHC) or a long-acting dihydropyridine (Amlodipine at Crossroads 
CHC) or non-dihydropyridine calcium channel blocker (CCB) (Verapamil at Crossroads CHC).44 
Unless there are other  compelling reasons, other agents are recommended only for the fourth or 
fifth line of treatment after contributing factors like adherence, white coat hypertension, 
secondary causes, and lifestyle, among others.44  More specifically, the guidelines do not 
consider Atenolol as appropriate routine first to third line treatment for hypertension because of 
its poor effect on reducing cardiovascular or myocardial mortality.44   Although just under 7 
percent (11 patients) of the non-psychiatric patients were on Atenolol and none of the psychiatric 
patients were taking it, this did not constitute a statistically significant difference (Table 3).  Only 
two of these patients were taking Atenolol as one of two antihypertensive agents (no compelling 
reasons noted), and three patients were taking Atenolol as one of the three anti-hypertensive 
agents prescribed for them.  One of the patients taking Atenolol as a third agent suffered from 
ischaemic heart disease, with the other two agents being a thiazide and an ACE-I.  The rest of the 
patients on Atenolol (6 patients) were taking four or more antihypertensive agents and one of 
them suffered from ischaemic heart disease.   
All other patients in both groups had one or all of the recommended first three lines of 
anti-hypertensive agents (Thiazide, ACE-I, CCB), in addition to other agents like Hydralazine 
and other types of diuretics, for those on more than three agents.  In other words, all patients in 
both groups on a single agent were taking hydrochlorothiazide (HCTZ), all other patients on two 
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both groups on three agents were taking all three recommended first to third line agents 
(Thiazide, CCB and ACE-I).      
 
Table 3.  Number of Antihypertensive Agents 




3 Agents > 3 Agents Patients on Atenolol 
Psych 
Percentage 
of total (n) 
32 (10) 41 (13) 19 (6) 9.4 (3) 0 
Non-Psych 
Percentage 
of Total (n) 
22 (36) 35 (57) 31 (49) 13 (21) 6.7 (11) 



















                                                
d 95% Confidence interval for difference between proportions cannot be calculated if one of the absolute values (n) 















 The club and preparation rooms at Crossroads CHC were found to have all the necessary 
equipment and materials for appropriate care of hypertension patients, except for a copy of the 
latest hypertension guidelines (Table 4).  Furthermore, there was no record of when the weight 
scale was last calibrated.  Assessment of the consulting rooms where these patients are seen 
revealed that the three consulting rooms for non-psychiatric patients had all the necessary 
material and equipment for the optimal care of hypertensive patients, except for two rooms 
which did not have tape measures and one which did not have a body mass index chart or wheel 
(Table 5). 
 In comparison, the singular consulting room where psychiatric patients are seen 
everyday, none of the required items was present (Table 5).     
  
Table 4.  Club and Preparation Room Contents 
 
 
A. Do the club and preparation rooms have the following items?  
 
Item Yes No 
1.  Functioning Scale (weight) x  
2.  Patient Education Leaflets x  
3.  Urine dipsticks x  
4.  Facilities for collecting urine x  
5.  Height Scale x  
6.  Latest Hypertension Guidelines  x 
7.  Mercury sphygmanometer or oscillometric device with standard 
Sized cuff. 
x  
8.  Large size cuff x  
 
 
B. Does the procedure/injection room have the following items? 
 
Item Yes No 
1.  Functioning ECG Machine x  
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in the past two years? 
 
Item Total Number Number Calibrated/Repaired Percentage 
Sphygmanometer 4 4 100 





















standard size cuff 
0 0 3 100 




0 0 3 100 
Tape Measure 0 0 1 33.3 
BMI 
Chart/Wheel 



























 One of the more notable differences between the two cohorts was the significant 
difference (p<0.0001) in the median number of visits. e  The psychiatric patients at Crossroads 
CHC tend to be seen on a monthly basis, and indeed the median number of visits for the 
psychiatric cohort was 8.50 (Standard deviation (SD)=2.69) compared to 3.00 (SD=1.48) visits 
for the non-psychiatric cohort.f That the psychiatric patients are seen more often provides an 
opportunity for hypertension care related activities to be performed.  However, most of these 
activities are recorded as having been performed less frequently for this group than they are 
performed for the non-psychiatric patients.  Diet education was given at least once during the 
period in question for only 25% of the psychiatric patients as opposed to 64% of the non-
psychiatric patients (p=0.0001), while education/advice about exercise was also provided to a 
significantly lower proportion (22%) of psychiatric patients than non-psychiatric patients (48%, 
p=0.006), as indicated in Table 6.1.  Nonetheless, this latter difference in percentage of patients 
given exercise advice at least once in the year, seems practically unimportant when the 95% 
confidence interval of the difference between the proportions (7.8 to 45) is considered.  The real 
difference between percentage of psychiatric versus non-psychiatric patients given exercise 
advice may be as high as 45%, but may be as low as 7.8% (e.g. 20% versus 27.8%), which is 
arguably a negligible difference in patient numbers (Table 6.1).  Similarly, while there is a 
significant difference between the groups (p=0.02) in the percentage of patients receiving 
education about their medication, the 95% confidence interval of this difference (4.6 to 41) has a 
negligible lower limit, suggesting that in the total populations the difference could be as small as 
4.6% (Table 6.1).  This is not a meaningful difference when comparing these proportions.   
 Probably the most crucial activity in the management of patients with hypertension is the 
actual measurement of the blood pressure at each visit.  Assessments of risk and decisions about 
further management are impossible without knowledge of a patient’s blood pressure.  A 
                                                
e This was calculated using the Mann-Whitney test because the non-psychiatric values were non-parametric.  
However, the t-test with Welch’s correction yielded the same p value (standard deviations were statistically 
significant).47 
f Using the t-test with Welch’s correction to compare means, the 95% confidence interval for the difference between 
the mean number of visits for the groups (4.45) was from 3.45 to 5.44 (i.e. the real difference between these means 
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comparison of the two groups reveals that for the non-psychiatric patients, almost all patients’ 
blood pressures were measured at each visit (99%), whereas only 9% of the psychiatric patients’ 
blood pressures were measured at every visit.  However, it is important to note that the 
psychiatric patients were seen every month for the psychiatric problems, and that most of these 
visits appropriately involve an assessment of mental health status and global assessment of 
function.  Arguably, it may not be beneficial to measure a patient’s blood pressure every month 
unless his/her blood pressure is uncontrolled and various changes are being made to the patient’s 
drug regimen.  Given that the non-psychiatric patients made an average of just under four visits 
in the year (3.87), it was helpful to examine how many psychiatric patients had at least 3 or more 
visits throughout the year where their blood pressure were measured.  The result was 71.9% (23 
patients), which was still significantly less than the proportion of non-psychiatric patients whose 
blood pressure was measured at every visit (p=0.001). 
   Other activities which were performed for a significantly lower proportion of 
psychiatric patients with hypertension than for non-psychiatric patients were the annual 
measurement of weight and the dipsticks testing of urine (Table 6.1 and 6.2).  There were also 
significantly lower proportions of psychiatric patients whose renal function and cardiac condition 
were objectively tested (serum creatinine levels and electrocardiograph (ECG)) at least once 
during the year in question) (Table 6.2).  Once again, however, while there may be a statistically 
significant difference between a proportion of 0% psychiatric patients compared to 5% of non-
psychiatric patients having an annual ECG (p=0.006), the difference is not meaningful to this 
particular comparison (Table 6.2).  Both proportions are low and it is clear that ECGs are not 
done very much for either group of patients at the clinic.  Lastly, the confidence interval of the 
difference between each group’s percentage of patients having annual serum creatinine levels 
measured also as a small lower limit (7.2 to 45), which suggests the possibility of a meaningless 
difference between the actual populations at the clinic with regard to the performance of this test (Table 
6.2). 
 It is interesting to note that the number of patients whose blood pressure was measured at 
each visit was equal to expected national standards (as defined by the South African 
Hypertension Guideline 2006) in the non-psychiatric group (Table 6.1).44 For both groups, none 
of the other variables were performed in a large enough proportion of patients to significantly 
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<0.0001  <0.0001  <0.0001 <0.0001 <0.0001 0.5 <0.0001 <0.0001 0.01 
 
                                                
g 95% Confidence interval for difference between proportions cannot be calculated if one of the absolute values (n) 
is less than 5. 
h Not determined.  Guidelines only state what the lifestyle requirements for blood pressure control are, but do not 
state how frequently counseling should be given.  However, it is reasonable to assume that this should be done at 
least once annually with every hypertensive patient even if it involves positive reinforcement of good lifestyle 
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i 95% Confidence interval for difference between proportions cannot be calculated if one of the absolute values (n) 















The proportion of psychiatric patients whose blood pressures at the end of the study 
period were less than 140/90 (controlled) was only just significantly greater (p=0.05) than the 
proportion of patients in the non-psychiatric cohort (Table 6).  In fact, when examined with the 
confidence interval of this difference, the lower confidence limit of 1.4%, suggests that the 
difference in the proportions for the actual populations in the clinic may be negligible (Table 6).  
However, there was also a significant difference in the median systolic pressures between the 
two groups at the end of the study period (Figure 1A, Table 6).  The median diastolic pressure 
was significantly much higher for the mental health patients (98mmHg vs. 90mmHg p=0.004), 
suggesting better blood pressure control for the non-psychiatric patients at the end of the period 
(Figure 1B, Table 6).  Lastly, the non-psychiatric patients had significantly higher proportions of 
patients whose last isolated systolic pressures or isolated diastolic pressures were controlled 
(49.1 % and 66.3% respectively.  See Table 6).  Once again, this difference for the last systolic 
pressures is negligible when examine alongside a confidence interval with a lower limit 


















Comparison of the median last recorded systolic and diastolic blood pressures between 
psychiatric and non-psychiatric hypertensive patients for the period May 2007-May 2008.  
Statistically significant difference is seen in Graph A between the median systolic blood 
pressures (p=0.05) where the median systolic pressure is higher for psychiatric patients.  Graph B 
also demonstrates a significantly higher last recorded median blood pressure for psychiatric 















Table 6.  Intermediate Outcome of Care Measures 
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j These t-test calculations are included for interest.  Note that given the non-parametric nature of the data, the t-test is 
an inappropriate test and the Mann-Whitney comparison of medians is more relevant.  T-test maintains significance 















 The results of this study demonstrate a significant difference between the care of 
psychiatric patients with hypertension and non-psychiatric hypertensive patients at Crossroads 
CHC, with regard to counselling about diet changes, the measurement of blood pressure at 
relevant visits, and the weighing of patients annually.  This difference is underpinned by the lack 
of all relevant equipment required for the care of hypertensive patient in the psychiatric 
consulting room.  The lack of a sphygmanometer in the room means that even basic 
measurement of blood pressure for these patients has to be done in the neighbouring emergency 
room.  While urinalysis is done centrally for all patients in the preparation room, the use of a 
scale in the psychiatry consulting room would enable the facile weighing of patients as part of 
the consultation.   
The overall median systolic and diastolic pressures of all the last visits of the twelve 
month period were also found to be significantly lower for the non-psychiatric patients than the 
psychiatric patients.  However, this difference (157/98 for psychiatric patients versus 147/90 for 
the non-psychiatric patients) is clinically and epidemiologically difficult to interpret as these two 
blood pressure measurements fall in the same hypertensive stage (I) and therefore carry the same 
prognosis when one does not consider added risk factors or target organ damage.44 As will be 
discussed further below, the poor recording of the presence of these added risk factors 
(significant family history, target organ damage, clinical cardiac disease, hypercholesterolaemia 
etc) renders it difficult to provide a more nuanced interpretation of the blood pressure 
measurements, and is one of the shortcomings of this study.  Thus, it may well be possible that 
the presence of these risk factors in one group more than the other, places it in a higher overall 
blood pressure stage in spite of the clinically similar blood pressure measurements.44 Conversely, 
it is also equally important to note that in various other randomised controlled trials involving 
treatment of hypertension, small differences in treated blood pressure between groups (e.g. mean 
reductions in blood pressure of less than 10mmHg of systolic or diastolic) have resulted in often 











Page | 36 
 
Interestingly, the proportion of non-psychiatric patients whose blood pressures were at 
target levels (41.7%) is similar to that found by Rayner et al. at two other Cape Town CHCs in 
2006 (39.8%) and to Steyn et al.’s findings at another Cape Town CHC in 1999 (42.1%).15, 16 
They compare poorly to the United States’ NHANES findings for 1999-2000 (53.1%), 
suggesting much need for improvement for all the Cape Town CHCs.18 Of course, these levels 
should be much lower for those patients with high risk (diabetes, heart failure, renal disease, 
etc).44    
The study therefore reveals important differences in the quality of care between the two 
groups of patients, while a clinical and epidemiological difference in the immediate outcomes 
(blood pressure control) between the two groups is less clear.  How and to what extent different 
aspects of the process of care of hypertensive patients (lifestyle counselling, regiment changes, 
routine testing for target organ damage, adherence monitoring, etc) impact on immediate 
outcomes (one or two years) like blood pressure control, is an interesting multivariate question 
beyond the scope of the current study.  As stated before, the national guidelines give specific 
recommendations with regard to the frequency with which certain process activities like the 
measuring of weight should be performed, but are obviously unable to give a recommendation 
on the frequency of interventions like diet and lifestyle counselling.44 These important aspects of 
care are expected by this study to have been performed at least once a year.  However, 
counselling should also be tapered to the patient’s needs and readiness, resulting in different 
levels of intensity, frequency and emphasis for each patient.52  At the risk of further digression, 
to examine how these interventions independently have an effect on immediate outcomes would 
be methodologically unwieldy to consider, but may be possible in a larger inter-site study that 
stratified and grouped patients using all possible confounding variables. 
Lastly, the study established that both groups at the clinic were managed in a substandard 
manner with regard to the processes of care, when compared to the current national guidelines, 
with the exception being the actual measurement of blood pressure at each visit for the non-


















 Perhaps one of the more obvious challenges and shortcomings of this study was its sole 
dependence on medical records as representations of the processes of care.  The author’s own 
personal experience at Crossroads clinic specifically, is that often the health education talks in 
the club room (given by the professional nurse to the patients), are not recorded in the folders as 
having been performed.  Thus, the assumption that activities which are not recorded were not 
performed is not entirely accurate.  Interestingly, the relationship between good clinical note-
taking and good quality clinical care is not simple.  Segovia refers to a multi-centre study (15 
medical centres in Segovia, Spain) performed by his group that attempts to examine the 
relationship between the quality of medical notes and the quality of care of diabetic patients.53   
Their findings ostensibly demonstrate (unfortunately the original article only in Spanish in Aten 
Primaria, an unavailable journal) better quality of medical records amongst the subset of patients 
on insulin who had had diabetes the longest, but who had the lowest levels of control as 
measured by their Haemoglobin A1C (HbA1C) levels.53 Overall, the entire population of patient 
charts in the study did not show a significant relationship between good quality of records and 
better HbA1C levels.53  Segovia introduces time as a possible confounder and proposes that it is 
possible for physicians to record certain data “at the appropriate moment within the evolution of 
the illness.”53 Thus, patients with good control may have certain data not recorded or its 
collection postponed, whereas physicians may be more vigilant with patients with poorer control, 
resulting in an apparent relationship between bad recording and good quality of care.53 Of 
course, another consideration is that the recording of certain data like a creatinine level for 
example, does not necessarily translate into better control in the form of a lower HbA1C.53  As 
stated before, the recording of such data can only act as a proxy that implies a certain vigilance 
and attention to quality, which is hoped will ultimately influence outcome.  
 In a cross-sectional survey of fifty-two Dutch general practices which care for 1641 
patients with diabetes type 2, Goudswaard et al. found no correlation (p=0.20 at practice level 
and p=0.51 at patient level) between completeness of medical records and a lower HbA1C.54  
The survey assessed the practices’ charts for the recording of eleven items which were deemed 
crucial to the good quality care of diabetic patients based on current guidelines.54  These items 
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recording of important activities like lifestyle counselling as well as retinal and foot screening.54     
The authors also propose that not recording an activity does not necessarily mean it has not been 
done.54   
Nonetheless, there remains an important medico-legal presumption that an unrecorded 
activity was not done.55 In a survey of 253 Colorado primary care physicians regarding a total of 
1614 primary care consultations over a six month period, not only was clinical information 
missing in 13% of the visits, but the surveyed clinicians felt that in 44% of these cases, this 
missing information was at least somewhat likely to result in an adverse clinical outcome.56  
Lastly, it is arguable that activities during the patient visit which involve the obtaining of 
objective data like weight, blood results, ECGs, urine dipsticks, etc. are more likely to be 
recorded only if performed, than activities like lifestyle counselling, which was included as a 
measure in this study but not in any of the abovementioned studies from the literature.  
Despite its crudeness, therefore, the presumption that unrecorded data means that it was 
not performed or obtained remains the only consistent presumption for any study involving 
medical records, where no other method of data collection (i.e. observation) is used to triangulate 
or confirm.  For example, whether or not the measurement of patients’ blood pressures was done 
according to accepted standards can only be confirmed by observation or re-measuring.  In their 
previously mentioned survey of hypertension management at two community health clinics 
(CHC) in Cape Town, Rayner et al. checked the patients’ blood pressures in a standardized 
manner which adhered to national guidelines in order to compare with blood pressure readings in 
the folders.15  This exercise was enabled by Rayner et al.’s access to resources which allowed 
them to use a re-trained nurse practitioner to check the blood pressures of all patients whose 
folders were involved in the study.15  Nonetheless, this endeavour does not address the problem 
of unrecorded activities like diet and lifestyle counselling, as well as blood results.  An approach 
to this problem may be a direct observation study using anonymous observers or actor patients to 
sit through club sessions and perhaps even consultations and note which activities were 
performed.  Their findings could then be compared to the notes in the folders.  Alternatively, exit 
interviews of patients in the form of questionnaires could enquire which aspects of the process of 
care were performed and again compare with what is recorded in the folders.  These methods are 
limited by their intrusive nature and their need for resources which were not available for the 










Page | 39 
 
triangulating the data collected from medical records.  Stange et al. exemplify this last assertion 
in their comparison of chart review to patient questionnaires and to direct observation with 
regard to the assessment of health service quality and delivery in outpatient medical services.57  
The researchers used direct observation as a gold standard against which to compare patients’ 
exit interview questionnaires and medical chart reviews for levels of recording or reporting of 
activities performed during consultations.57 4454 visits by patients to 138 family physicians were 
directly observed by trained nurse observers, after which charts were reviewed using a validated 
instrument and patients also given a standardised validated exit interview.57  Interestingly, the 
patient exit interviews were found to confirm the occurrence of lifestyle counselling during the 
consultation much better than the chart reviews, whereas there was higher concordance of chart 
reviews with direct observation with regard to recording physical examinations and some 
outpatient procedures like pap smears.57 The study methodology was relatively thorough, 
including close analysis of interater reliability (mostly high), validity of instruments, follow-up 
of lost cases (i.e. patients who opted to mail their exit interviews instead of completing them 
after the consultation, and patients who refused to participate), and factoring for the Hawthorne 
effect (by including folders of patients for whose visits a direct observer had not been present).57 
Thus, in the absence of the potentially intrusive direct observation, using patient exit interviews 
might have been a valuable method of ascertaining whether any lifestyle counselling occurred 




 Another possible limitation of this study was its restriction to a twelve month period.  The 
twelve month period was used because according to the guidelines, most of the activities 
pertaining to the process of care of hypertensive patients (i.e. urinalysis and serum creatinine and 
cholesterol analysis) should be performed at least once in a twelve month period.44 It also 
provides a good baseline assessment from which an annual quality assurance cycle can be 
implemented, making it convenient for planning.  However, for some patients, some of the 
process of care activities being examined may have been performed the month just before the 
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be given.  Therefore, it may have been more accurate to look at a period of two years or eighteen 
months.  Little consensus exists as to the best length of time for audits to examine, with periods 
ranging from one year to five.48 Nonetheless, in their critical review of British general 
practitioners’ hypertension audits, Cranney et al. caution against not exceeding five years as 
standards and guidelines change over time.48 
This study used the last measured blood pressure of the period in question as a 
measurement of intermediate outcome.  As mentioned previously, using only one blood pressure 
reading has its limitations.44 Often, patients attend the clinic so early in the morning that they 
have not taken their pills, resulting in elevated blood pressure readings which probably more 
accurately depict their medications’ trough levels of blood pressure control, but not an overall 
picture of control.  Furthermore, a patient whose blood pressure was well controlled throughout 
the year, might have missed his/her appointment at the end of the year and therefore attended the 
clinic after a few weeks without medication, thus having an elevated blood pressure at the last 
visit of the period being studied.  These possible scenarios would give an impression of poor 
control if this last blood pressure reading were the only one used.   Nonetheless, these random 
actualities are arguably equally likely for blood pressures taken at earlier visits during the year. 
An average of the last two or three readings of the period in question may have helped to 
decrease the effect of these random variations, but as stated before this would be difficult to 
interpret as an approximation of outcome, particularly with patients who had only visited the 
clinic twice.  In addition, the times between measurements vary between patients, during which 
interventions like exercise may have different effects.44 Lastly, recording the difference between 
the first blood pressure reading of the period and the last, is another possible method for 
measuring outcomes, which was not mentioned in any of the audit literature found.  This method 
provides for looking at gradients of the difference, so that although target blood pressures are not 
reached, a downward trend can be used to demonstrate the effects of interventions.    
 Yet another shortcoming of the study, (particularly as the beginning of an exercise in 
quality improvement for the clinic) was to neglect to examine more thoroughly the patterns of 
practice.  While the prescription of the appropriate recommended classes of anti-hypertensive 
agents at the clinic was very good, the response by clinicians to uncontrolled levels of blood 
pressure throughout the year was not examined in the review of the records.  This is an important 
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regarding the process of care and subsequently, further areas for intervention and improvement.  
The national guidelines give specific timelines and intervals for different levels of blood 
pressure, including how often to titrate doses or add more agents when blood pressure is 
uncontrolled, how often blood pressure should be measured once control is achieved, when to 
refer to higher levels of care, and how soon control should be achieved for all stages of blood 
pressure.44  Adherence to these recommendations should also be a part of any exercise in quality 







 Apart from the proposed differences in process of care activities, numerous confounding 
factors may have contributed to the albeit minor differences in median blood pressures seen 
between the two groups of patients at the end of the twelve month period.  Differing levels of 
adherence may have contributed to these differences.  Previously mentioned studies have found 
lower levels of blood pressure control among patients with major depression and that patients 
with psychosis have lower adherence to their antihypertensive medication than psychotic 
patients.41,42,43 These may well contribute to the higher levels of blood pressure in the psychiatric 
group.41,42,43  While education about medication—for which there was a statistically significant 
(p=0.02), but substantively uninteresting difference (CI for difference between percentages: (4.6, 
41)) between the two groups—can be seen as a proxy for adherence counselling, an better 
assessment of adherence might have helped with comparing the two groups.  Of course, 
adherence is notoriously difficult to measure, particularly in a system without electronic records, 
unlike the United States’ Veterans Administration records mentioned in previous studies which 


















As part of a continuing exercise in quality improvement, the following recommendations 
are made for the clinic’s medical staff to implement as a team:  
1. The purchasing of all required equipment (sphygmanometer with standard-sized and 
large-sized cuff, tape measure) for the psychiatric consulting room and easily 
accessible records calibration dates for all sphygmanometers. 
2. Psychiatric patients with hypertension to begin their visits at the club room in order 
to participate in the group educational sessions that occur there and to be reviewed 
by the primary care doctor on call after their psychiatric clinic consultation at least 
four times a year (or more if uncontrolled and regimen changes are made, in keeping 
with the national guidelines).  The formalised inclusion of mental health patients in 
the club room will also fit very well with the integrative aspirations of the state and 
province’s comprehensive service plan for Healthcare 2010, regarding mental health 
care, as well as begin to create better awareness and less stigmatization of mental 
health patients.44 Some of the more stable psychiatric patients may indeed benefit 
from separate dates for their hypertension club visits.  Four (or more, depending on 
their level of control and interventions) of their monthly visits to the clinic each year 
could be substituted for club visits, where the primary reason for the visit is their 
hypertension.  Their mental status and other aspects of their mental health could be 
assessed with reasonable competence by the primary care doctor at these times.      
3. Training of all relevant staff (doctors, nursing staff in the club and preparation 
rooms, the psychiatric professional nurse) in the process of care requirements for 
hypertensive patients using the national guidelines, so that all involved can better 
monitor and coordinate the provision of care activities for these patients.  This entails 
updated protocols (i.e. aligned with the 2006 national guidelines) for the frequency 
of certain preparation room and club room tasks (e.g. proper blood pressure 
measuring technique, weighing of patients, BMI calculations, etc).  It also includes a 
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to levels of control, when and how to titrate, to add treatment or to refer, and how to 
risk stratify patients (this naturally implies better history taking and record keeping 








The results of this study suggest a lower quality of some aspects of care of psychiatric 
patients with regards to their hypertension, and add to the previously mentioned body of 
literature suggesting the poor management of medical conditions amongst patients with 
psychiatric patients.  Of course, it is impossible to isolate a specific reason (i.e. prejudice and 
stigmatization) for these differences, particularly at Crossroads CHC where the aforementioned 
structural obstacles and deficits exist.  Beyond the basic structural obstacles, other possible 
explanations do include the ongoing marginalization of patients with psychiatric illnesses.     
Numerous factors are possible, some of which (as mentioned in the recommendations), are easily 
surmountable.  Beyond this, the study reveals that the quality of the process of care of both 
groups of patients at this clinic is significantly lower than the expected national standards.  This 
arguably translates into the low percentage of patients (22% Psychiatric patients and 42% non-
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